Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.
- NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_assertion wasGeneratedBy ECO_0000203 NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.
- NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_assertion wasDerivedFrom befree-2016 NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.
- NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_assertion SIO_000772 23086750 NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.
- NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_assertion evidence source_evidence_literature NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.
- NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_assertion description "[We have assessed the impact of these mutations in a cohort of 494 patients treated within the randomized phase 3 United Kingdom Leukaemia Research Fund Chronic Lymphocytic Leukemia 4 (UK LRF CCL4) trial that compared chlorambucil and fludarabine with and without cyclophosphamide in previously untreated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1022914.RAMOF4Vr1MRcMu_wpiUsJQw6ZSAaZUdyuNxSKf2G79lrU130_provenance.